• Cystatin B (CSTB) Gene Mutation Analysis
  • Erythropoietin
  • Complement Component CH50
  • Thyrotropin Receptor Antibody
  • Alveolar Rhabdomyosarcoma (ARMS) by Reverse Transcriptase PCR (RT-PCR)
  • Creatinine, Serum
  • Nexilin-like Protein (NEXN) Gene Mutation Analysis
  • Gastrointestinal Viral Pathogen Panel, Molecular
  • IsoPSA Test
  • Cyclin-Dependent Kinase-Like 5 (CDKL5) Mutation Analysis
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Cancer Antigen (CA) 19-9, Serum
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Cancer Antigen (CA) 19-9, Serum
Medical Test

Turnaround Time
Access to Cancer Antigen (CA) 19-9, Serum is restricted.